ADAMTS13 and kidney failure: We included three patients presenting MAHA and thrombocytopenia in the absence of kidney failure, with an ADAMTS13 activity of between 10% and 30% and positive title of IgG anti‐ADAMTS13 antibodies (Figure 4).